Fatty Acid Esterification as a NASH Therapeutic Target

被引：1
|
作者：
Sakuma, Ikki [1 ]
Vatner, Daniel F. [1 ,2 ,3 ,4 ]
机构：
[1] Yale Sch Med, Dept Internal Med, New Haven, CT USA
[2] Yale Sch Med, Program Translat Biomed, New Haven, CT USA
[3] Vet Affairs Med Ctr, Dept Med, West Haven, CT USA
[4] Yale Sch Med, Dept Internal Med, 300 Cedar St,POB 208020, New Haven, CT 06520 USA
来源：
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 17卷 / 02期
关键词：
INSULIN-RESISTANCE; HEPATIC STEATOSIS; MICE; ACYLTRANSFERASE-1; DEFICIENT;
D O I：
10.1016/j.jcmgh.2023.10.011
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [41] Overexpression of Fatty Acid Synthase as a Potential Therapeutic Target in Classical Hodgkin Lymphoma
    Jabcuga, Christine
    Nguyen, Andy
    Covinsky, Michael
    Brown, Robert E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A284 - A284
  • [42] Free Fatty Acid Receptor Family: A New Therapeutic Target for Metabolic Diseases
    Hirasawa, Akira
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (06): : 769 - 777
  • [43] Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease
    Sun, Dan-Qin
    Wu, Sheng-Jie
    Liu, Wen-Yue
    Lu, Qian-Di
    Zhu, Gui-Qi
    Shi, Ke-Qing
    Braddock, Martin
    Song, Dan
    Zheng, Ming-Hua
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (03) : 375 - 387
  • [44] Obeticholic acid: expanding the therapeutic landscape of NASH
    Arrese, Marco
    Cabrera, Daniel
    Barrera, Francisco
    ANNALS OF HEPATOLOGY, 2015, 14 (03) : 430 - 432
  • [45] RELATION OF FATTY ACID STRUCTURE TO RELEASE AND ESTERIFICATION OF FREE FATTY ACIDS
    HOLLENBERG, CH
    ANGEL, A
    AMERICAN JOURNAL OF PHYSIOLOGY, 1963, 205 (05): : 909 - &
  • [46] Fatty acid levels in nonalcoholic steatohepatitis (NASH) and fatty liver.
    Lau, Y
    Hatch, G
    Minuk, GY
    HEPATOLOGY, 1999, 30 (04) : 546A - 546A
  • [47] Hepatic Oxalate Overproduction As A Driver And Therapeutic Target In NASH And Atherosclerosis
    Das, Sandeep
    Finney, Alexandra C.
    Kumar, Dhananjay
    Liu, Yuhao
    Rohilla, Sumati
    Anand, Sumit Kumar
    Nunez, Kelly
    Liu, Zhipeng
    Pearson-Gallion, Brenna
    Abdullah, Chowdhury S.
    Cockerham, Elizabeth D.
    Bhuiyan, Md Shenuarin
    Orr, Wayne W.
    Garcia-Barrio, Minerva T.
    Zhang, Jifeng
    Liu, Wanqing
    Chen, Y. Eugene
    Thevenot, Paul
    Cohen, Ari
    Yurdagul, Arif
    Rom, Oren
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [48] Role and effective therapeutic target of gut microbiota in NAFLD/NASH
    Liu, Qun
    Liu, Shousheng
    Chen, Lizhen
    Zhao, Zhenzhen
    Du, Shuixian
    Dong, Quanjiang
    Xin, Yongning
    Xuan, Shiying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (03) : 1935 - 1944
  • [49] TNF-α as therapeutic target in NASH:: tried, but not yet proven
    Chitturi, Shivakumar
    Farrell, Geoffrey C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (05) : 613 - 614
  • [50] Dynamic simulation of steam distillation in a fatty acid esterification
    Jacobmeier, O
    Mehrwald, A
    Meier, A
    FETT-LIPID, 1999, 101 (10): : 370 - 378
12345